These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1257276

  • 1. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K, Grünheid K.
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract] [Full Text] [Related]

  • 2. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B, Förster W, Mest HJ, Schrör K.
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract] [Full Text] [Related]

  • 3. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW, Boyksen D.
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract] [Full Text] [Related]

  • 4. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
    von Philipsborn G.
    Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
    [No Abstract] [Full Text] [Related]

  • 5. [The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics].
    Mertens HM, Schelbert HR, Kreuzer H, Spiller P, Schmiel FK.
    Arzneimittelforschung; 1973 May; 23(5):642-5. PubMed ID: 4740203
    [No Abstract] [Full Text] [Related]

  • 6. [Chronic toxicity of 4-[3'-diethylamino-2'hydroxypropyl]-ajmaline hydrogen tartrate (Tachmalcor) in the rat].
    Grimm I, Sziegoleit W, Riedel H, Förster W.
    Pharmazie; 1976 May; 31(1):44-7. PubMed ID: 3809
    [No Abstract] [Full Text] [Related]

  • 7. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B, Förster W.
    Pharmazie; 1976 May; 31(9):635-9. PubMed ID: 1019213
    [No Abstract] [Full Text] [Related]

  • 8. [Structure-activity relationship in various 4-substituted ajmaline derivatives].
    Femmer K, Gabsch G, Braun K.
    Pharmazie; 1976 May; 31(1):36-9. PubMed ID: 1257277
    [No Abstract] [Full Text] [Related]

  • 9. [Action of 17-monochloro-acetylajmaline, a new anti-arrhythmia drug, upon myocardial contractility].
    Bardet J, Roudy G, Rocha P, Riguad M, Mathivat A, Bourdarias JP.
    Ann Cardiol Angeiol (Paris); 1974 May; 23(6):539-44. PubMed ID: 4618072
    [No Abstract] [Full Text] [Related]

  • 10. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
    Iervasi G, Clerico A, Bonini R, Nannipieri M, Manfredi C, Sabatino L, Biagini A, Donato L.
    Int J Clin Pharmacol Res; 1998 May; 18(3):109-20. PubMed ID: 9825267
    [Abstract] [Full Text] [Related]

  • 11. The pharmacology of Norpace.
    Dean RR.
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract] [Full Text] [Related]

  • 12. [Antiarrhythmic activity of trimecaine in experimental arrhythmia and its effect on the heart conduction system].
    Gendenshteĭn EI, Kostin IaV.
    Farmakol Toksikol; 1976 Jan; 39(4):426-8. PubMed ID: 1027568
    [Abstract] [Full Text] [Related]

  • 13. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N, Kawada M, Fukutomi Y.
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
    Nakayama K, Koike H, Oshima T, Hashimoto K.
    Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative study of the effects of various antiarrhythmic drugs on the frequency of ventricular response during established atrial fibrillation].
    Bracchetti D, Frabetti L, Mambelli M, Stefanini A, Magnani B.
    Boll Soc Ital Cardiol; 1977 Feb; 22(1):51-5. PubMed ID: 911535
    [No Abstract] [Full Text] [Related]

  • 16. [The anti-arrhythmia action of combinations of N-propylajmaline bromide with anti-arrhythmia agents of different classes].
    Gendenshteĭn EI, Balashov VP, Kostin IaV, Oleĭnikov VE.
    Farmakol Toksikol; 1990 Feb; 53(1):30-2. PubMed ID: 1691716
    [Abstract] [Full Text] [Related]

  • 17. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
    Lisin N, Carlier J.
    Acta Cardiol; 1974 Feb; Suppl 18():117-30. PubMed ID: 4547497
    [No Abstract] [Full Text] [Related]

  • 18. [The antiarrhythmic action mechanism of verapamil (Isoptin)].
    Bass O, Friedemann M.
    Schweiz Med Wochenschr; 1971 May 29; 101(21):792-9. PubMed ID: 5143469
    [No Abstract] [Full Text] [Related]

  • 19. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part II. Thiopental anesthesia.
    Orszulak-Michalak D, Trzaskalska M.
    Pol J Pharmacol; 1995 May 29; 47(2):153-62. PubMed ID: 8688888
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
    Verdouw PD, Remme WJ, Beaune J, Rutteman AM, Hagemeijer F.
    Arzneimittelforschung; 1976 May 29; 26(8):1558-61. PubMed ID: 1036951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.